Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis
Nicolas J. Schlienz(Behavioral Pharma (United States)), Ryan G. Vandrey(Behavioral Pharma (United States)), Ronald Flegel(Substance Abuse and Mental Health Services Administration), Tory R. Spindle(Johns Hopkins University), George E. Bigelow(Johns Hopkins University), John M. Mitchell(RTI International), Evan S. Herrmann(Johns Hopkins University), Edward J. Cone(National Institute on Drug Abuse), Charles LoDico(Substance Abuse and Mental Health Services Administration)
Cited by 92
Related Papers
Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults
|JAMA Pediatrics|2017|1.2k
Blood Cannabinoids. I. Absorption of THC and Formation of 11-OH-THC and THCCOOH During and After Smoking Marijuana*
|Journal of Analytical Toxicology|1992|520
Methamphetamine and Amphetamine Pharmacokinetics in Oral Fluid and Plasma after Controlled Oral Methamphetamine Administration to Human Volunteers
|Clinical Chemistry|2003|264
Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis
|JAMA Network Open|2018|259
Changing landscape of cannabis: novel products, formulations, and methods of administration
|Current Opinion in Psychology|2019|254